| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | See Remarks
1 company
Townsend Adam J. is a Chief Commercial Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $3.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 695 | $29.52 | $20,518.90 | -0.8% | -38.2% | -21.8% | |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 3,323 | $30.43 | $101,103.94 | -3.8% | -42.8% | -27.6% | |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 2,201 | $29.96 | $65,938.00 | -2.4% | -39.2% | -33.4% | |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 2,685 | $28.70 | $77,065.14 | -2.9% | -32.4% | -25.4% | |
| Feb 12, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 1,148 | $67.77 | $77,796.40 | -1.2% | -36.5% | -57.9% | |
| Jan 29, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 906 | $64.14 | $58,109.21 | -1.0% | -26.8% | -55.2% | |
| Jan 22, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 3,413 | $65.00 | $221,831.35 | -3.5% | -27.2% | -54.0% | |
| Jan 16, 2024 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 2,235 | $66.81 | $149,317.22 | -2.2% | -22.3% | -56.2% | |
| Dec 1, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 110,000 | $60.81 | $6,689,303.46 | -36.0% | +0.6% | -44.9% | |
| May 3, 2023 | APLS Apellis Pharmaceuticals, Inc. | Chief Commercial Officer | Sale+OE | 5,000 | $82.71 | $413,550.00 | -6.2% | -71.5% | -44.1% |